Barbara L. Hoesterey

Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins

Seiji Kageyama, Barry Anderson, Barbara L. Hoesterey et al. · Antimicrobial Agents and Chemotherapy · 1994 · 64 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Solubilization of Thiazolobenzimidazole Using a Combination of pH Adjustment and Complexation with 2-Hydroxypropyl-β-Cyclodextrin

Abdi Y. Tinwalla, Barbara L. Hoesterey, T.-X. Xiang et al. · Pharmaceutical Research · 1993 · 63 citations

Pharmacy, Pharmaceutics, Pharmacology +12

Solubilization of a Tripeptide HIV Protease Inhibitor Using a Combination of Ionization and Complexation with Chemically Modified Cyclodextrins

Mark D. Johnson, Barbara L. Hoesterey, Bradley D. Anderson · Journal of Pharmaceutical Sciences · 1994 · 62 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +14

Uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats: intravenous infusion studies.

Brian D. O. Anderson, Barbara L. Hoesterey, Diana Baker et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 53 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Brain and cerebrospinal fluid uptake of zidovudine (AZT) in rats after intravenous injection

Raymond E. Galinsky, Barbara L. Hoesterey, Bradley D. Anderson · Life Sciences · 1990 · 41 citations

Pharmacy, Pharmacokinetics, Pharmacology +9